Serum BAFF expression in patients with myasthenia gravis

Jee Young Kim, Young Yang, Joon Shik Moon, Eun Young Lee, Sun Hwha So, Hong Soo Lee, Kee Duk Park, Young Chul Choi

Research output: Contribution to journalArticlepeer-review

46 Scopus citations


A B-cell activating factor of the tumor necrosis factor (TNF) family (BAFF) is an essential B-cell survival factor. Myasthenia gravis (MG) is one of the most typical antibody-mediated autoimmune disorders. To test whether serum BAFF levels are increased in MG patients, we compared the serum BAFF levels of 40 MG patients with those of 30 healthy controls. Serum BAFF levels of MG group were significantly higher than those of healthy group. These results suggested that the BAFF might play a role in the immunopathogenesis of MG and further study on B-cell and T-cell activation may be needed.

Original languageEnglish
Pages (from-to)151-154
Number of pages4
JournalJournal of Neuroimmunology
Issue number1-2
StatePublished - 13 Aug 2008


  • B lymphocyte stimulator
  • BAFF
  • Myasthenia gravis (MG)


Dive into the research topics of 'Serum BAFF expression in patients with myasthenia gravis'. Together they form a unique fingerprint.

Cite this